315:
312:
132:
Youle is a board or committee member of the
British HIV Association (responsible for the British HIV therapeutic guidelines), International Association of Physicians in AIDS Care and the MANON Therapeutic Vaccine Programme. He is a trustee of the Red Hot AIDS Charitable Trust and a medical advisor to
219:
112:
as applied to HIV therapy. His studies in health economics and health outcomes have helped to provide evidence to budget holders to fund HIV treatment within the UK. Other recent research interests include
65:
in London, the earliest specialist centre combining HIV care and research in the UK, he was the centre's
Clinical Trials Co-ordinator from 1986 to 1996. In 1990–91, he served as a consultant for the
433:
428:
423:
233:
Chancellor JV, Hill AM, Sabin CA, Simpson KN, Youle M. (1997) Modelling the cost effectiveness of lamivudine/zidovudine combination therapy in HIV infection.
94:
408:
291:
69:'s Global Programme on AIDS and the National Programme on AIDS in Kampala. Youle has been Director of HIV Clinical Research at the
62:
146:
200:
181:
438:
235:
392:
134:
66:
90:
58:
32:
376:
268:
443:
121:
28:
192:
101:, Canada in 2006. This was followed up by expanding the concept in publication, in collaboration with
448:
78:
70:
24:
331:
Youle M Wainberg MA J Int Assoc
Physicians AIDS Care (Chic Ill). 2003 Jul-Sep;2(3):102-5. Review.
288:
74:
349:
256:
196:
177:
362:
BHIVA: Guidelines for the treatment of HIV-1 positive adults with antiretroviral therapy 2012
109:
40:
295:
173:
45:
417:
380:
350:
NAM: HIV Treatment Update: A healthy – and happy – old age with HIV (22 October 2012)
319:
214:
102:
361:
217:. (2003) Pre-exposure chemoprophylaxis (PREP) as an HIV prevention strategy.
141:
20:
43:
of HIV therapy. In 1995, he was listed as one of 40 influential gay men by
373:
77:(now UCL Medical School) since 1996. He held a visiting professorship at
98:
114:
313:
8th
European Drug Resistance Workshop: Mike Youle, B Med Sci, MB ChB
289:
Goldsmiths: Centre for the Study of
Invention and Social Process
340:
Beck E.J , Youle M et al,Int J STD AIDS. 2008 May;19(5):297-304
73:
in London and
Honorary Senior Lecturer in Public Health at the
36:
61:
in 1984. One of the founders of the Kobler Clinic of
308:
306:
304:
89:Youle is noted for introducing the concept of mass
75:Royal Free & University College Medical School
409:Royal Free ICDC HIV clinical trials research team
124:on the TILT, ALCAR, COLATE and VANGUARD studies.
272:: Moving into the mainstream (27 November 1995)
8:
284:
282:
280:
152:Getting it Right Safer Sex for Young Gay Men
187:Youle M, Clarbour J, Wade P, Farthing C.
128:Education, memberships and trustee roles
249:
434:Academics of University College London
429:Alumni of the University of Sheffield
7:
424:21st-century English medical doctors
220:J. Int. Assoc. Physicians AIDS Care
168:Palfreeman A, Youle M, Farthing C.
95:XVIth International AIDS Conference
93:for HIV to a wider audience at the
393:British Film Institute: Mike Youle
63:Chelsea & Westminster Hospital
14:
140:Youle has presented two films on
133:the National AIDS Manual and the
189:AIDS Therapeutics in HIV Disease
147:The Gay Man's Guide to Safer Sex
31:. He publicised the concept of
257:Duedil: Dr Michael Simon Youle
1:
465:
395:(accessed 7 February 2013)
383:(accessed 7 February 2013)
364:(accessed 7 February 2013)
352:(accessed 7 February 2013)
322:(accessed 7 February 2013)
298:(accessed 7 February 2013)
274:(accessed 7 February 2013)
259:(accessed 7 February 2013)
135:Elton John AIDS Foundation
17:Michael (Mike) Simon Youle
67:World Health Organization
19:(born 1960) is a British
117:in HIV-positive people.
91:pre-exposure prophylaxis
59:Sheffield Medical School
33:pre-exposure prophylaxis
122:principal investigator
374:NAM: Medical advisors
193:Churchill Livingstone
170:Drugs in HIV and AIDS
439:HIV/AIDS researchers
108:He has also studied
53:Education and career
39:and has studied the
79:Belgrade University
71:Royal Free Hospital
57:Youle qualified at
25:clinical researcher
294:2012-12-05 at the
236:PharmacoEconomics
120:He has served as
456:
396:
390:
384:
371:
365:
359:
353:
347:
341:
338:
332:
329:
323:
310:
299:
286:
275:
266:
260:
254:
158:Key publications
110:health economics
99:Toronto, Ontario
41:health economics
27:specializing in
464:
463:
459:
458:
457:
455:
454:
453:
414:
413:
405:
400:
399:
391:
387:
372:
368:
360:
356:
348:
344:
339:
335:
330:
326:
311:
302:
296:Wayback Machine
287:
278:
267:
263:
255:
251:
246:
230:
228:Research papers
210:
174:Wiley-Blackwell
165:
160:
130:
87:
55:
46:The Independent
12:
11:
5:
462:
460:
452:
451:
446:
441:
436:
431:
426:
416:
415:
412:
411:
404:
403:External links
401:
398:
397:
385:
379:2013-04-15 at
366:
354:
342:
333:
324:
318:2013-04-12 at
300:
276:
261:
248:
247:
245:
242:
241:
240:
229:
226:
225:
224:
209:
206:
205:
204:
185:
164:
161:
159:
156:
129:
126:
86:
83:
54:
51:
13:
10:
9:
6:
4:
3:
2:
461:
450:
447:
445:
444:Living people
442:
440:
437:
435:
432:
430:
427:
425:
422:
421:
419:
410:
407:
406:
402:
394:
389:
386:
382:
381:archive.today
378:
375:
370:
367:
363:
358:
355:
351:
346:
343:
337:
334:
328:
325:
321:
320:archive.today
317:
314:
309:
307:
305:
301:
297:
293:
290:
285:
283:
281:
277:
273:
271:
265:
262:
258:
253:
250:
243:
238:
237:
232:
231:
227:
222:
221:
216:
212:
211:
207:
202:
198:
194:
190:
186:
183:
179:
175:
171:
167:
166:
162:
157:
155:
153:
149:
148:
143:
138:
136:
127:
125:
123:
118:
116:
111:
106:
104:
103:Mark Wainberg
100:
96:
92:
84:
82:
80:
76:
72:
68:
64:
60:
52:
50:
48:
47:
42:
38:
34:
30:
29:HIV treatment
26:
22:
18:
388:
369:
357:
345:
336:
327:
269:
264:
252:
234:
218:
188:
169:
151:
145:
139:
131:
119:
107:
88:
56:
44:
16:
15:
449:1960 births
270:Independent
215:Wainberg MA
172:(2nd edn) (
150:(1992) and
35:(PREP) for
418:Categories
244:References
223:2: 102–105
201:044304029X
182:0471970638
239:12: 54–66
213:Youle M,
195:; 1988) (
176:; 1998) (
142:safer sex
81:in 2004.
377:Archived
316:Archived
292:Archived
154:(1993).
85:Research
208:Reviews
199:
180:
115:ageing
21:doctor
163:Books
197:ISBN
178:ISBN
23:and
97:in
37:HIV
420::
303:^
279:^
144:,
137:.
105:.
49:.
203:)
191:(
184:)
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.